136 related articles for article (PubMed ID: 17391632)
1. The synthesis and initial characterization of an immobilized purinergic receptor (P2Y1) liquid chromatography stationary phase for online screening.
Moaddel R; Calleri E; Massolini G; Frazier CR; Wainer IW
Anal Biochem; 2007 May; 364(2):216-8. PubMed ID: 17391632
[No Abstract] [Full Text] [Related]
2. Are P2Y1 purinoceptors expressed in turkey erythrocytes?
Sak K
Neurosci Lett; 2000 Oct; 293(1):78-80. PubMed ID: 11065143
[TBL] [Abstract][Full Text] [Related]
3. Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites.
Moro S; Guo D; Camaioni E; Boyer JL; Harden TK; Jacobson KA
J Med Chem; 1998 Apr; 41(9):1456-66. PubMed ID: 9554879
[TBL] [Abstract][Full Text] [Related]
4. 2-Chloro N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate is a selective high affinity P2Y(1) receptor antagonist.
Boyer JL; Adams M; Ravi RG; Jacobson KA; Harden TK
Br J Pharmacol; 2002 Apr; 135(8):2004-10. PubMed ID: 11959804
[TBL] [Abstract][Full Text] [Related]
5. Comparison of P2 receptor subtypes producing dilation in rat intracerebral arterioles.
Horiuchi T; Dietrich HH; Hongo K; Dacey RG
Stroke; 2003 Jun; 34(6):1473-8. PubMed ID: 12730558
[TBL] [Abstract][Full Text] [Related]
6. [32P]2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate ([32P]MRS2500), a novel radioligand for quantification of native P2Y1 receptors.
Houston D; Ohno M; Nicholas RA; Jacobson KA; Harden TK
Br J Pharmacol; 2006 Mar; 147(5):459-67. PubMed ID: 16299552
[TBL] [Abstract][Full Text] [Related]
7. HEK293 human embryonic kidney cells endogenously express the P2Y1 and P2Y2 receptors.
Schachter JB; Sromek SM; Nicholas RA; Harden TK
Neuropharmacology; 1997 Sep; 36(9):1181-7. PubMed ID: 9364473
[TBL] [Abstract][Full Text] [Related]
8. Characterization of P2X3, P2Y1 and P2Y4 receptors in cultured HEK293-hP2X3 cells and their inhibition by ethanol and trichloroethanol.
Fischer W; Wirkner K; Weber M; Eberts C; Köles L; Reinhardt R; Franke H; Allgaier C; Gillen C; Illes P
J Neurochem; 2003 May; 85(3):779-90. PubMed ID: 12694404
[TBL] [Abstract][Full Text] [Related]
9. Two disparate ligand-binding sites in the human P2Y1 receptor.
Zhang D; Gao ZG; Zhang K; Kiselev E; Crane S; Wang J; Paoletta S; Yi C; Ma L; Zhang W; Han GW; Liu H; Cherezov V; Katritch V; Jiang H; Stevens RC; Jacobson KA; Zhao Q; Wu B
Nature; 2015 Apr; 520(7547):317-21. PubMed ID: 25822790
[TBL] [Abstract][Full Text] [Related]
10. 2-Chloro-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate is a selective high affinity P2Y1 receptor antagonist: commentary on Boyer et al.
King BF
Br J Pharmacol; 2002 Apr; 135(8):1839-40. PubMed ID: 11959784
[No Abstract] [Full Text] [Related]
11. Caged agonist of P2Y1 and P2Y12 receptors for light-directed facilitation of platelet aggregation.
Gao ZG; Hechler B; Besada P; Gachet C; Jacobson KA
Biochem Pharmacol; 2008 Mar; 75(6):1341-7. PubMed ID: 18199424
[TBL] [Abstract][Full Text] [Related]
12. Acyclic and cyclopropyl analogues of adenosine bisphosphate antagonists of the P2Y1 receptor: structure-activity relationships and receptor docking.
Kim HS; Barak D; Harden TK; Boyer JL; Jacobson KA
J Med Chem; 2001 Sep; 44(19):3092-108. PubMed ID: 11543678
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of the P2Y(1) receptor with a high affinity radiolabeled antagonist.
Waldo GL; Corbitt J; Boyer JL; Ravi G; Kim HS; Ji XD; Lacy J; Jacobson KA; Harden TK
Mol Pharmacol; 2002 Nov; 62(5):1249-57. PubMed ID: 12391289
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of a recombinant P2Y purinoceptor.
Simon J; Webb TE; King BF; Burnstock G; Barnard EA
Eur J Pharmacol; 1995 Nov; 291(3):281-9. PubMed ID: 8719412
[TBL] [Abstract][Full Text] [Related]
15. Alanine-(87)-threonine polymorphism impairs signaling and internalization of the human P2Y11 receptor, when co-expressed with the P2Y1 receptor.
Haas M; Shaaban A; Reiser G
J Neurochem; 2014 May; 129(4):602-13. PubMed ID: 24524250
[TBL] [Abstract][Full Text] [Related]
16. Metabotropic P2Y1 receptors inhibit P2X3 receptor-channels in rat dorsal root ganglion neurons.
Gerevich Z; Müller C; Illes P
Eur J Pharmacol; 2005 Oct; 521(1-3):34-8. PubMed ID: 16181623
[TBL] [Abstract][Full Text] [Related]
17. Ribose modified nucleosides and nucleotides as ligands for purine receptors.
Jacobson KA; Ravi RG; Nandanan E; Kim HS; Moro S; Kim YC; Lee K; Barak D; Marquez VE; Ji XD
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):333-41. PubMed ID: 11563046
[TBL] [Abstract][Full Text] [Related]
18. Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
Kim HS; Ravi RG; Marquez VE; Maddileti S; Wihlborg AK; Erlinge D; Malmsjö M; Boyer JL; Harden TK; Jacobson KA
J Med Chem; 2002 Jan; 45(1):208-18. PubMed ID: 11754592
[TBL] [Abstract][Full Text] [Related]
19. Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2'-deoxyadenosine 3',5'-bisphosphate.
Boyer JL; Mohanram A; Camaioni E; Jacobson KA; Harden TK
Br J Pharmacol; 1998 May; 124(1):1-3. PubMed ID: 9630335
[TBL] [Abstract][Full Text] [Related]
20. 2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists.
Kim HS; Ohno M; Xu B; Kim HO; Choi Y; Ji XD; Maddileti S; Marquez VE; Harden TK; Jacobson KA
J Med Chem; 2003 Nov; 46(23):4974-87. PubMed ID: 14584948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
